Serum prohepcidin concentration: No association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women

British Journal of Nutrition

Volumn 97, Issue 3, 2007, Pages 544-549

  Roe, Mark A ^a   Spinks, Caroline ^a   Heath, Anne Louise M ^b   Harvey, Linda J ^a   Foxall, Rob ^a   Wimperis, Jennie ^c   Wolf, Christian ^d   Fairweather Tait, Susan J ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d HAHN MEITNER INSTITUT   (Germany)

Author keywords

Haemochromatosis; HFE genotype; Iron absorption; Iron status; Pregnancy; Prohepcidin

Indexed keywords

FERRITIN; FERROUS GLUCONATE; HEPCIDIN; HFE PROTEIN; IRON; PLACEBO; PROHEPCIDIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; ANTIANEMIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER; FERROUS ION; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE DETECTION; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON THERAPY; MALE; PHLEBOTOMY; PREDICTION; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; WILD TYPE; ADOLESCENT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; GENETICS; HETEROZYGOTE; INTESTINE ABSORPTION; IRON INTAKE; METHODOLOGY; MUTATION; PHYSIOLOGY; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; FEMALE; FERRITINS; FERROUS COMPOUNDS; GENOTYPE; HEMATINICS; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTESTINAL ABSORPTION; IRON, DIETARY; MALE; MEMBRANE PROTEINS; MUTATION; PHLEBOTOMY; PREGNANCY; PRENATAL CARE; PROTEIN PRECURSORS; SINGLE-BLIND METHOD;

EID: 34047261779     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507336829     Document Type: Article

References (31)

1. Bridle KR, Frazer DM, Wilkins SJ, et al. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669-673.
2. Brookes MJ, Sharma NK, Tselepis C & Iqbal TH (2005) Serum prohepcidin: measuring active hepcidin or a non-functional precursor? Gut 54 169-170.
3. Carter P (1971) Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem 40, 450-458.
4. Dallalio G, Fleury T & Means RT (2003) Senim hepcidin in clinical specimens. Br J Haematol 122, 996-1000.
5. Ezeh C, Ugochukwu CC, Weinstein J & Okpala I (2005) Hepcidin, haemoglobin and ferritin levels in sickle cell anaemia. Eur J Haematol 74, 86-88.
6. Flowers CA, Kuizon M, Beard JL, Skikne BS, Covell AM & Cook JD (1986 A serum ferritin assay for prevalence studies of iron deficiency. Am J Hematol 23, 141-151.
7. Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C & Stremmel W (2003) Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 102 371-376.
8. Heath A-L & Fairweather-Tait S (2003) Health implications of iron overload: The role of diet and genotype. Nutr Rev 61, 45-62.
9. Hsu SP, Chiang CK, Chien CT & Hung KY (2006) Plasma prohepcidin positively correlates with hematocrit in chronic hemodialysis patients. Blood Purif 24, 311-316.
10. Hunter HN, Fulton DB, Ganz T & Vogel HJ (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277, 37597-37603.
11. Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H & Swinkels D (2005) Novel urine hepcidin assay by mass spectrometry. Blood 106, 3268-3270.
12. Krause A, Neitz S, Mäigert H-J, Schulz A, Forssmann WG, Schulz-Knappe P & Adermann K (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147-150.
13. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B & Stremmel W (2004) Pro-hepcidin: Expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53, 735-743.
14. Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, Janetzko A, Cetin Y & Stremmel W (2005) The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184, 361-370.
15. Laftah AH, Ramesh B, Simpson RJ, Solanky N, Bahram S, Schumann K, Debnam ES & Srai SKS (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 102, 3940-3944.
16. Liang S, Clarke W, Chan D & Zhang Z (2006) Novel assay for hepcidin by surface-enhanced laser desorption/ionization mass spectrometry. A158-A158 D118 Suppl. S Clin Chem 52,.
17. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A & Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461-2463.
18. Nemeth E, Tuttle MS, Powelson J, Vaughan MB, Donovan A, Ward DM, Ganz T & Kaplan J (2004a) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
19. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK & Ganz T (2004b) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113, 1271-1276.
20. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A & Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98, 8780-8785.
21. Nicolas G, Bennoun M, Porteu A, et al. (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99, 4596-4601.
22. Park CH, Valore EV, Waring AJ & Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the Ever. J Biol Chem 276 7806-7810.
23. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P & Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276, 7811-7819.
24. Development Core Team (2003) R: A Language and Environment for Statistical Computing. http://www.R-project.org
25. Roe MA, Heath A-LM, Oyston SL, et al. (2005) Iron absorption in C282Y heterozygotes. Am J Clin Nutr 81, 814-821.
26. Schümann K, Kroll S, Weiss G, Frank J, Biesalski HK, Daniel H, Friel J & Solomons NW (2005) Monitoring of hematological, inflammatory and oxidative reactions to acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers. Toxicology 212, 10-23.
27. Taes YE, Wuyts B, Boelaert JR, De Vriese AS & Delanghe JR (2004) Prohepcidin' accumulates in renal insufficiency. Clin Chem Lab Med 24, 387-389.
28. Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H & Ishikawa I (2006) Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 108, 1381-1387.
29. Walker AP, Partridge J, Srai SK & Dooley JS (2004) Hepcidin: What every gastroenterologist should know. Gut 53, 624-627.
30. Willis G, Scott DG, Jennings BA, Smith K, Bukhari M & Wimperis JZ (2002) HFE mutations in an inflammatory arthritis population. Rheumatology 41, 176-179.
31. Yamaji S, Sharp P, Ramesh B & Srai SK (2004) Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 104, 2178-2180.